Synapse - Mark Kris

Results (872)

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin, a new antifolate

Journal Article

Krug, L. M.; Ng, K. K.; Kris, M. G.; Miller, V. A.; Tong, W.; Heelan, R. T.; Leon, L.; Leung, D.; Kelly, J.; Sirotnak, F. M.
Clinical Cancer Research (2000)

Fulltext@MSK | Save

Final report of the 70.2-Gy and 75.6-Gy dose levels of a phase I dose escalation study using three-dimensional conformal radiotherapy in the treatment of inoperable non-small cell lung cancer

Journal Article

Rosenzweig, K. E.; Mychalczak, B.; Fuks, Z.; Hanley, J.; Burman, C.; Ling, C. C.; Armstrong, J.; Ginsberg, R.; Kris, M. G.; Raben, A.; more...
The Cancer Journal (2000)

Fulltext@MSK | Save

Phase I trial of docetaxel and vinorelbine in patients with advanced nonsmall cell lung carcinoma

Journal Article

Miller, V. A.; Ng, K. K.; Krug, L. M.; Perez, W.; Pizzo, B.; Heelan, R. T.; Kris, M. G.
Cancer (2000)

Fulltext@MSK | Save

Phase II study of dolastatin-10 in patients with advanced non-small-cell lung cancer

Journal Article

Krug, L. M.; Miller, V. A.; Kalemkerian, G. P.; Kraut, M. J.; Ng, K. K.; Heelan, R. T.; Pizzo, B. A.; Perez, W.; McClean, N.; Kris, M. G.
Annals of Oncology (2000)

Fulltext@MSK | Save

Chemotherapy-induced nausea and vomiting

Book Section

Pisters, K. M. W.; Kris, M. G.
In Pazdur, R.; Coia, L. R.; Hoskins, W. J.; Wagman, L. D. (Eds.) Cancer Management: A Multidisciplinary Approach. 3rd ed (1999)

Fulltext@MSK | Save

Phase II trial of docetaxel and vinorelbine in advanced non-small cell lung cancer (NSCLS) with analysis of bcl-2 and bax expression

Meeting Abstract

Krug, L. M.; Filippa, D. A.; Kris, M. G.; Zelenetz, A.; Heelan, R. T.; Grant, S. C.; Ng, K. K.; Pizzo, B. A.; Miller, V. A.
Proceedings of the American Association for Cancer Research Annual Meeting (1999)

Fulltext@MSK | Save

Paclitaxel and carboplatin prior to surgery in early stage non-small cell lung cancer (NSCLC)

Meeting Abstract

Pisters, K. M. W.; Ginsberg, R. J.; Putnam, J. B.; Johnson, D. H.; Roberts, J. R.; Kris, M. G.; Crowley, J.; Bunn, P. A.
Seminars in Oncology (1999)

Fulltext@MSK | Save

Phase I and pharmacokinetic study of 10-propargyl-10-deazaaminopterin (PDX), a new antifolate

Meeting Abstract

Krug, L. M.; Ng, K. K.; Miller, V. A.; Heelan, R. T.; Tong, W.; Kelly, J.; Sirotnak, F. M.; Kris, M. G.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Efficacy of cytotoxic agents against human tumor xenografts is markedly enhanced by co-administration of ZD1839 (Iressa™), an inhibitor of EGF receptor tyrosine kinase

Meeting Abstract

Sirotnak, F. M.; Miller, V. A.; Scher, H. I.; Kris, M. G.
Clinical Cancer Research (1999)

Fulltext@MSK | Save

Phase I study of oral ZD1839 (Iressa™), a novel inhibitor of epidermal growth factor receptor tyrosine kinase (EGFR-TK): Evidence of good tolerability and activity

Meeting Abstract

Kris, M.; Ranson, M.; Ferry, D.; Hammond, L.; Averbuch, S.; Ochs, J.; Rowinsky, E.
Clinical Cancer Research (1999)

Fulltext@MSK | Save